|
Volumn 4, Issue 11, 2009, Pages 1793-1795
|
Chemical and structural biology to direct the repurposing of sulindac
|
Author keywords
Cancer; Chemical biology; Medicinal chemistry; NMR; Protein ligand interactions
|
Indexed keywords
CLAVULANIC ACID;
DISHEVELLED PROTEIN;
FRIZZLED PROTEIN;
IMATINIB;
MEROPENEM;
NONSTEROID ANTIINFLAMMATORY AGENT;
SULINDAC;
SULINDAC SULFONE;
WNT PROTEIN;
CHRONIC MYELOID LEUKEMIA;
DRUG BINDING;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG STRUCTURE;
DRUG TARGETING;
GASTROINTESTINAL STROMAL TUMOR;
GENOME ANALYSIS;
GENOTYPE PHENOTYPE CORRELATION;
HETERONUCLEAR SINGLE QUANTUM COHERENCE;
HUMAN;
INFLAMMATION;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PAIN;
PDZ DOMAIN;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
PROTEIN PROTEIN INTERACTION;
SHORT SURVEY;
TUBERCULOSIS;
TUMOR GROWTH;
ADAPTOR PROTEINS, SIGNAL TRANSDUCING;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BINDING SITES;
COMPUTER SIMULATION;
CYCLOOXYGENASE INHIBITORS;
PHOSPHOPROTEINS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PROTEIN STRUCTURE, TERTIARY;
SIGNAL TRANSDUCTION;
SULINDAC;
WNT PROTEINS;
|
EID: 73449127608
PISSN: 18607179
EISSN: 18607187
Source Type: Journal
DOI: 10.1002/cmdc.200900384 Document Type: Short Survey |
Times cited : (3)
|
References (8)
|